Chemical and Pharmaceutical Bulletin · 2001 · 16 citations · 14 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Space ExplorationEnzyme InhibitionLead Compound DesignLigand-based DesignMolecular DockingProtein-ligand DockingAromatic Ring ReplacementChemical Synthesis Of AnaloguesMedicinal Chemistry ApplicationsMolecular Docking Of InhibitorsPyrimidine AnalogsPyrimidine AnaloguesPyrimidine ChemistryTernary Complex Formation
A series of novel pyrrolo[2,3-d]pyrimidine derivatives was designed and synthesized as thymidylate synthase (TS) inhibitors. Molecular design was performed on the human TS complex model built on the basis of the reported structure of TS-deoxyuridinemonophosphate (dUMP)-CB3717 ternary complex. From a docking study, we expected that a one-carbon bridge between pyrrolo[2,3-d]pyrimidine and an aromatic ring was suitable. Moreover, we found that the bridge carbon could be replaced with an alkyl group to fill out the unoccupied space. Based on this design, we synthesized five pyrrolo[2,3-d]pyrimidine derivatives with one-carbon bridge and evaluated their TS inhibitory activities. All synthesized compounds inhibited TS more potently than compound 2 (LY231514), and the C8-ethyl analogue (7) showed a remarkable inhibitory activity against TS (IC50=0.017 microM).
14
Edward C. Taylor, Dietmar Kuhnt, Chuan Shih et al. · Journal of Medicinal Chemistry · 1992 · 252 citations · Full text
An Isotopic Assay for Thymidylate Synthetase<sup>*</sup>
DeWayne Roberts · Biochemistry · 1966 · 212 citations